-
Alzheimer’s drug lecanemab that slows decline given green light in UK – but won’t be available on NHS | UK News
admin
A drug that can slow the debilitating symptoms of Alzheimer’s has been approved by the UK’s medicines regulator. In an unusual double-header assessment by UK authorities, the Medicines and Healthcare products Regulatory Agency (MHRA) has said the drug lecanemab is safe and effective enough for doctors to prescribe, but a separate NHS watchdog has ruled…
-
Gene therapy costing over £1.6m is approved for NHS patients with inherited blood disorder | UK News
admin
Patients in England with an inherited blood disorder are to become the first in Europe to benefit from a gene therapy costing well over one million pounds a shot. The treatment, called Casgevy, uses ‘molecular scissors’ to disable a faulty gene that causes the debilitating condition beta-thalassaemia. Currently people severely affected by the disease need…
-
NHS software provider faces £6m fine after hackers steal tens of thousands of medical records | UK News
admin
A major NHS IT provider faces a penalty of just over £6m for failures which led to a cyber attack and the theft of nearly 83,000 medical records. The Information Commissioner’s Office (ICO) has been investigating Advanced, which supplies vital systems for the health service, since the breach on 4 August 2022. The cyber attack…
-
delay, dementia, herpes, News, NHS, onset, Science, shingles, significantly, study, suggests, targeting, Tech, vaccine, virus, zoster
NHS shingles vaccine targeting herpes zoster virus could significantly delay onset of dementia, study suggests | Science & Tech News
admin
A vaccine being used by the NHS to prevent shingles could also significantly delay the onset of dementia, according to new research that has left scientists baffled. The study on more than 200,000 older people shows those who were given the ‘recombinant’ vaccine Shingrix were diagnosed with dementia an average of 164 days later than…
-
Global IT outage: NHS warns of GP disruption next week – as travellers report long delays and lost baggage | UK News
admin
The NHS has warned of “continued disruption” to GP services into next week following the global IT outage – as airline passengers reported lengthy delays and lost baggage this weekend. The outage spread globally on Friday morning after an update from global cybersecurity firm CrowdStrike knocked many Microsoft Windows PCs offline with a “blue screen…
-
beach, body, consequences, dangerous, doctor, drugs, loss, News, NHS, people, ready, risk, senior, warns, weight
People taking weight loss drugs to get ‘beach body ready’ risk ‘dangerous consequences’, senior NHS doctor warns | UK News
admin
People are risking “dangerous consequences” by using “powerful” weight loss drugs to get “beach body ready”, a senior NHS doctor has warned. Professor Stephen Powis, NHS England’s national medical director, said he was concerned about medications such as Ozempic and Wegovy being used by people who are “otherwise healthy” and “just want to lose a…
-
Electric headset for treating depression recommended as widespread treatment after NHS trial | UK News
admin
An electric headset for treating depression has been recommended as a more widespread treatment for depression after a successful NHS trial. But it’s not yet known what the long term benefits of the device are. An NHS trial has found that an innovative electric headset for treating depression is an effective way of reducing the…
-
‘Large volume’ of data stolen from NHS Dumfries and Galloway published on dark web | UK News
admin
A ransomware group has carried out its threat against a Scottish health board and published a “large volume” of stolen data on the dark web. NHS Dumfries and Galloway was the subject of a cyber attack in March and confirmed hackers were able to access a “significant quantity of data”, including patient and staff-identifiable information.…
-
Take-at-home brain cancer treatment for children will soon be available on NHS | UK News
admin
Children with brain tumours will soon have access to drugs they can take at home, the NHS has announced. The treatment is a first of its kind and clinical trials have shown it to significantly slow the progression of the disease, allowing children a better quality of life for longer. The treatment is for children…
-
Migraine pill which could help 170,000 sufferers given NHS green light | UK News
admin
A migraine pill which could change the lives of thousands of people who suffer from the “incredibly debilitating” condition should be made accessible on the NHS “swiftly”, a charity has said. Atogepant – sold under the brand name Aquipta and made by AbbVie – has been given the green light for NHS use under new…